Equities

Nyxoah SA

Nyxoah SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)9.54
  • Today's Change-0.10 / -1.04%
  • Shares traded50.10k
  • 1 Year change+31.77%
  • Beta0.3909
Data delayed at least 15 minutes, as of May 16 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

  • Revenue in EUR (TTM)4.35m
  • Net income in EUR-43.21m
  • Incorporated2009
  • Employees147.00
  • Location
    Nyxoah SARue Edouard Belin 12MONT-SAINT-GUIBERT 1435BelgiumBEL
  • Phone+32 26121755
  • Fax+32 10459075
  • Websitehttps://www.nyxoah.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pulsion Medical Systems SE31.67m5.41m143.53m66.0026.725.2121.104.530.65490.65493.843.360.97111.773.88479,840.0016.5820.3721.2431.1763.6655.9617.0724.121.7715.740.001,227.726.103.02-8.06----0.00
Bastide Le Confort Medical SA523.32m6.32m150.00m3.55k27.951.851.830.28660.72990.77265.5711.020.79555.446.90147,580.701.842.492.663.5250.5448.822.313.050.8111.920.8391--8.4811.9411.2417.556.98--
Stille AB31.10m3.06m150.47m142.0032.492.7132.854.846.006.0060.2071.840.53641.777.183,416,557.005.277.036.358.1946.7643.939.829.850.98797.170.0021.9819.7016.78-2.485.3423.62--
Onward Medical NV0.00-36.18m166.56m99.00--8.10-----1.20-1.200.000.5940.00----0.00-60.19-55.70-68.71-61.60-------79,513.95---58.040.4848---34.62---10.40--32.59--
Prim SA216.51m12.67m173.77m900.0013.691.387.650.80260.7450.74512.737.401.121.994.10240,567.406.586.689.248.9037.9338.115.856.431.22--0.1681--9.7710.0051.02-2.1412.86--
Bactiguard Holding AB18.96m-10.84m188.76m191.00--7.23--9.95-3.60-3.606.309.800.30354.286.001,017,544.00-17.35-7.56-19.82-8.8129.8747.91-57.15-26.281.64-11.900.4129---11.966.46-161.71--8.43--
Sedana Medical AB (publ)14.16m-1.96m199.20m83.00--2.3534,110.5614.07-0.2299-0.22991.669.950.15641.248.102,087,443.00-2.17-5.77-2.28-6.0870.5064.06-13.85-36.137.38--0.0043--25.2321.5918.90--42.12--
Detection Technology Oyj-100.00bn-100.00bn238.89m478.00--3.28----------4.97----------9.34--11.96--47.44--8.223.13--0.08153.455.292.027.55-18.03-14.88-9.55
Tristel Plc46.04m7.04m243.85m213.0035.026.7024.455.300.12560.12560.82190.65670.9921.516.26185,394.4015.178.8617.1010.2482.5980.6315.2910.633.93411.730.1605109.9915.7010.14351.986.409.8818.05
Semperit Holding AG721.08m25.13m244.00m4.58k9.660.57373.910.33841.23-0.816235.1720.670.80984.688.24157,578.902.795.253.607.3222.4624.793.455.591.384.920.342686.85-7.54-3.87-34.59---7.21--
Medistim ASA45.64m8.82m275.90m152.0031.237.4525.326.045.605.6029.0123.481.030.77656.153,492,704.0019.9522.9324.0728.5279.0278.2519.3120.642.99--0.020675.257.0010.06-8.9112.720.03314.87
Nyxoah SA4.35m-43.21m276.30m147.00--2.82--63.55-1.55-1.550.15553.420.03220.78912.0629,618.53-31.98-23.73-35.88-25.9861.9162.42-993.86-1,469.594.50--0.1147--40.99---38.39--100.58--
BICO Group AB194.04m-138.03m277.98m837.00--1.09--1.43-22.34-26.3931.7342.970.33982.334.142,555,996.00-24.19---27.59--50.48---71.20--1.95-13.810.3933--6.09---1,889.33------
Lumibird SA203.56m7.13m294.32m1.05k36.811.5212.031.450.35590.35599.148.620.52381.094.05193,497.101.833.132.443.9961.6861.763.505.891.622.470.42870.006.6015.12-37.23-2.4718.34--
COLTENE Holding AG246.48m12.13m319.18m1.20k26.283.2416.721.292.002.0040.6216.211.331.406.58201,937.606.5310.4810.9018.7464.2462.684.927.470.80455.620.317279.94-9.133.54-54.05-6.81-7.72-7.79
IVF Hartmann Holding AG150.24m15.38m331.45m304.0021.552.1615.792.216.316.3161.6363.070.80153.088.46486,687.508.217.299.998.9053.9053.2910.248.303.89--0.005652.16-1.792.0934.951.49-14.8326.82
Data as of May 16 2024. Currency figures normalised to Nyxoah SA's reporting currency: Euro EUR

Institutional shareholders

10.63%Per cent of shares held by top holders
HolderShares% Held
BlackRock Advisors LLCas of 04 Apr 2024653.98k2.28%
BNP Paribas Asset Management Belgium SAas of 30 Apr 2024482.84k1.69%
Opaleye Management, Inc.as of 31 Dec 2023344.80k1.20%
Swedbank Robur Fonder ABas of 29 Feb 2024318.53k1.11%
Fidelity Management & Research Co. LLCas of 31 Mar 2024298.20k1.04%
Schroder Investment Management Ltd.as of 31 Jan 2024289.65k1.01%
Sio Capital Management LLCas of 31 Dec 2023200.08k0.70%
Putnam Investment Management LLCas of 28 Mar 2024192.94k0.67%
BNP Paribas Asset Management Europe SASas of 29 Nov 2023133.31k0.47%
AXA Investment Managers (Paris) SAas of 31 Oct 2023131.00k0.46%
More ▼
Data from 31 Dec 2023 - 07 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.